Systemic Response to Injury Flashcards
Protein signaling compounds that mediate cellular responses
Cytokines
Cytokine: Induces muscle breakdown and cachexia through increased catabolism
TNF-α
Cytokine: Induces fever through prostaglandin activity in anterior hypothalamus
IL-1
Cytokine: Promotes β-endorphin release from pituitary
IL-1
Cytokine: Promotes lymphocyte proliferation and Ig production
IL-2
Cytokine: Elicited by all immunogenic cells as a mediator of acute phase response
IL-6
Cytokine: Prolongs activated neutrophil survival
IL-6
Cytokine: Chemoattractant for neutrophils, basophils, eosinophils, and lymphocytes
IL-8
Cytokine: Activates macrophages via Th1 cells
IFN-γ
Protect cells from deleterious effects of traumatic stress and, when released by damaged cells, alert the immune system of the damage
Heat shock proteins
Bind both autologous and foreign proteins and thereby function as intracellular chaperones for ligands such as bacterial DNA and endotoxin
Heat shock proteins
Cause cell injury through oxidation of unsaturated fatty acids within cell membranes
ROS
Derived primarily by oxidation of membrane phospholipid arachidonic acid
Eicosanoids
Enzyme involved in the oxidation of membrane phospholipid arachidonic acid
PLA2
Action of phospholipase A2 is inhibited by
Corticosteroids
Arachidonic acid undergoes the COX pathway to generate (2)
Cyclic endoperoxidases
1) PG
2) TXA2
Arachidonic acid undergoes the LOX pathway to generate (2)
HPETE (5-Hydroperoxyeicosatetraenoic acid)
1) HETE (5-Hydroxyicosatetraenoic acid)
2) Leukotrienes
MOA of Aspirin (NSAID prototype)
Nonselectively and irreversibly inhibits COX (COX-1 and 2)
Aspirin anti-inflammatory effect is mediated by
Inhibition of COX-2 thereby inhibition of TXA2 production by platelets and decreases platelet aggregation
GI toxicity of NSAIDs is mediated by
Inhibition of COX-1 hence PG synthesis (for HCO3 and mucous secretion)
A viral illness for which aspirin is used is associated with what syndrome in children
Reye syndrome
Reye syndrome is characterised by (2)
Acute non-inflammatory
1) Encephalopathy
2) Fatty degenerative liver failure
Nonselective but reversible COX inhibitors (2)
1) Indomethacin
2) Ketorolac
Selective COX-2 inhibitor with reduced risk of GI toxicity
Celecoxib